Inventor
FACCHINI PETER J
CA26 patents
⚠️ This page may combine multiple inventors who share the name “FACCHINI PETER J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENVERIC BIOSCIENCES CANADA INC
25 patentsUS11707447B1Jul 25, 2023
C4-carbonothioate-substituted tryptamine derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC4 citations73
US11891359B2Feb 6, 2024
Prenylated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations62
US12138276B2Nov 12, 2024
Halogenated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations61
US11998557B2Jun 4, 2024
Halogenated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations61
US11945778B2Apr 2, 2024
C4-carbonothioate-substituted tryptamine derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations61
US11845726B2Dec 19, 2023
C4-carbonothioate-substituted tryptamine derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations61
US12378195B2Aug 5, 2025
Aminated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US12187679B2Jan 7, 2025
Hydroxylated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US12133856B2Nov 5, 2024
Multi-substituent psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US12128058B2Oct 29, 2024
Multi-substituent psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US11931338B2Mar 19, 2024
Nitrilated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US11918594B2Mar 5, 2024
Multi-substituent psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US11891360B2Feb 6, 2024
Glycosylated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US11858895B2Jan 2, 2024
Aminated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US11845727B2Dec 19, 2023
Aldehyde and ketone derivatives of psilocybin and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US11752130B2Sep 12, 2023
Carboxylated psilocybin derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations60
US12492179B2Dec 9, 2025
Substituted ethylamine fused heterocyclic mescaline derivatives
ENVERIC BIOSCIENCES CANADA INC0 citations59
US12358885B2Jul 15, 2025
Substituted n-propylamine fused heterocyclic mescaline derivatives
ENVERIC BIOSCIENCES CANADA INC0 citations59
US12195439B1Jan 14, 2025
C1-substituted isopropylamine fused heterocyclic mescaline derivatives
ENVERIC BIOSCIENCES CANADA INC0 citations59
US12077498B2Sep 3, 2024
C4-carboxylic acid-substituted tryptamine derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations59
US12065404B2Aug 20, 2024
C4-carboxylic acid-substituted tryptamine derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations59
US11746087B1Sep 5, 2023
C4-carboxylic acid-substituted tryptamine derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations59
US12577232B2Mar 17, 2026
N-heterocycle substituted tryptamine derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations58
US12338231B1Jun 24, 2025
N-heterocycle substituted tryptamine derivatives and methods of using
ENVERIC BIOSCIENCES CANADA INC0 citations58
US12428408B2Sep 30, 2025
Fused heterocyclic mescaline derivatives
ENVERIC BIOSCIENCES CANADA INC0 citations48